Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2016

Townsend EC, Murakami MA, Christodoulou A, Christie AL, Köster J, DeSouza TA, et al. The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice. Cancer Cell. 2016;29(4):574-586.

Avecilla ST, Goss C, Bleau S, Tonon J-, Meagher RC. How do I perform hematopoietic progenitor cell selection? Transfusion. 2016;56(5):1008-12.

Halteh P, Magro CM, Lipner SR. Subungual pleomorphic fibroma: a case report and review of the literature. Dermatol Online J. 2016;22(11).

Zhang Y, Huang Y, Cantalupo A, Azevedo PS, Siragusa M, Bielawski J, et al. Endothelial Nogo-B regulates sphingolipid biosynthesis to promote pathological cardiac hypertrophy during chronic pressure overload. JCI Insight. 2016;1(5).

Pisapia DJ, Rosenblum MK, Lavi E. CD1a Reactivity in Non-neoplastic Adenohypophysis. Am J Surg Pathol. 2016;40(6):812-7.

Sargent JL, Li Z, Aliprantis AO, Greenblatt M, Lemaire R, Wu M-, et al. Identification of Optimal Mouse Models of Systemic Sclerosis by Interspecies Comparative Genomics. Arthritis Rheumatol. 2016;68(8):2003-15.

Chang JB, Quinnies KM, Realubit R, Karan C, Rand JH, Tatonetti NP. A novel, rapid method to compare the therapeutic windows of oral anticoagulants using the Hill coefficient. Sci Rep. 2016;6:29387.

Spina V, Khiabanian H, Messina M, Monti S, Cascione L, Bruscaggin A, et al. The genetics of nodal marginal zone lymphoma. Blood. 2016;128(10):1362-73.

Sarwar M, Semenas J, Miftakhova R, Simoulis A, Robinson B, Wingren AG, et al. Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells. Oncotarget. 2016;7(39):63065-63081.

Wang SA, Tam W, Tsai AG, Arber DA, Hasserjian RP, Geyer JT, et al. Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified. Mod Pathol. 2016;29(8):854-64.